This page includes the latest FDA filings for Aclaris Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ACRS | DUNS 032365882 |
Device Company | Device | Date |
---|---|---|
Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-12-06 |
Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-10-25 |
Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-06-25 |
Aclaris Therapeutics, Inc., James Alexander Corp. | Prescription Medication | 2019-03-28 |
Aclaris Therapeutics, Inc. | Eskata | 2017-12-14 |
Aclaris Therapeutics, Inc. | Eskata | 2017-12-14 |
Aclaris Therapeutics, Inc. | Rhofade | 2017-01-18 |
SEC | 0001557746 | Aclaris Therapeutics, Inc. of DELAWARE |